Chest Drainage System Market Outlook for (2023 to 2033)

Global chest drainage system sales are projected to exhibit Y-o-Y growth of 5.7% in 2023, totaling US$ 1,034.25 million. Over the assessment period, chest drainage system demand is predicted to rise at a CAGR of 5.7%. By 2033, the global chest drainage system market size is set to reach US$ 1,795.93 million.

Attributes Key Insights
Global Chest Drainage System Market Revenue (2022) US$ 977.91 million
Estimated Chest Drainage System Market Size (2023) US$ 1,034.25 million
Projected Chest Drainage System Market Value (2033) US$ 1,795.93 million
Chest Drainage System Value CAGR (2023 to 2033) 5.7%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Key Highlights from the Report

Market to Expand 1.7X through 2033

The global chest drainage system market is projected to expand 1.7X through 2033, amid a 1.4% increase in estimated CAGR compared to the historical one. This is attributable to rising cases of cardiovascular diseases, expanding healthcare facilities, growing health awareness, and favorable government policies.

Pleural Drainage Systems to Generate Substantial Revenue

As per the latest report, pleural drainage systems segment is expected to hold a prominent share in terms of product. This is due to rising demand for pleural drainage systems, also known as chest tube drainage systems, from hospitals, specialty clinics, and ambulatory surgical centers.

The management of thoracic and respiratory disorders, including pneumothorax, pleural effusion, and empyema, depends heavily on pleural drainage systems. They are gaining wider popularity among end users for draining the pleural space.

Pleural drainage systems, especially digital ones, are widely used to remove blood, air, and other fluids from the pleural space. Growing demand for pleural cavity drainage systems from hospitals and other healthcare settings will boost the target segment. Key manufacturers will likely expand their pleural drainage system portfolios to gain maximum profits.

North America to Nearly Account 28% Sales through 2033

North America is predicted to remain the leading consumer of chest drainage systems during the assessment period. It will likely contribute about 28% of global sales by 2033. This is attributable to factors such as,

  • Rising prevalence of pleural effusion: North American countries like the United States are witnessing high prevalence of pleural effusion and other pleural diseases. According to an article published in the National Library of Medicine, pleural effusion affects 1.5 million patients per year in the United States. This is driving demand for chest drainage systems as they are often employed during pleural effusion treatments.
  • Development and popularity of advanced digital drainage systems: North America-based manufacturers are constantly innovating to develop advanced digital drainage systems. These novel systems are revolutionizing chest drainage management and will boost the overall chest drainage system market revenue through 2033.
  • Increasing healthcare spending: The government spending on healthcare and budgetary allocations for medical devices is also positively impacting the North America chest drainage system market.

Chest Drainage System Market Overview

Chest drainage systems, or thoracic or chest tube drainage systems, have become essential chest drainage management solutions. They are a highly preferred choice by medical professionals for removing fluid, blood, or air from the pleural space or pleural cavity.

Demand for chest drainage systems is expected to rise rapidly during the forecast period. This is due to factors like rising cases of respiratory conditions, expanding healthcare infrastructure, and growing popularity of advanced digital drainage systems (DDS) in chest drainage management.

Chest drainage systems are the preferred mode of treatment opted for by patients for diseases including pneumothorax, hemothorax, and pleural effusion. Rising incidence of these diseases will likely create revenue-generation opportunities for chest drainage system manufacturers.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Historical Performance vs. Chest Drainage System Market Forecast 2023 to 2033

Historical CAGR (2018 to 2022) 4.3%
Forecast CAGR (2023 to 2033) 5.7%

Global sales of chest drainage systems grew at a CAGR of 4.3% in the last five years, from 2017 to 2022. They account for around 36.8% of global surgical drainage device sales. Total chest drainage system revenue reached about US$ 977.91 million in 2022.

Over the forecast period, chest drainage system demand is anticipated to rise at a CAGR of 5.7%. By 2033, the worldwide chest drainage system market value is set to reach US$ 1,795.93 million by 2033. This is due to rising cases of cardiovascular and respiratory diseases, expanding healthcare infrastructure, and surging popularity of advanced chest drainage management devices.

Cardiovascular disease (CVD) is prevalent and one of the leading causes of death worldwide, claiming an estimated 17.9 million lives each year. Chest drainage devices are predicted to become more popular as the healthcare industry seeks to combat cardiovascular illnesses' rising prevalence and recurrence.

The World Health Organization (WHO) estimates that 17.9 million people died from cardiovascular diseases (CVDs) in 2019, accounting for 32% of all fatalities. Heart attacks and strokes were to blame for 85% of these fatalities. This positively impacts chest drainage system sales, and the trend is expected to continue through 2033.

The prevalence of congestive heart failure (CHF) is expected to increase, with researchers predicting around 46% increase in the rate of heart failure prevalence by 2030. This will create a high demand for medical devices like chest drainage systems.

Other Key Factors Driving Growth in Chest Drainage System Market

Integration of digital technologies into chest drainage systems

The integration of digital technologies into chest drainage systems is gaining momentum. Sales are gaining momentum for systems equipped with digital sensors and interfaces that enable real-time monitoring and data collection.

Digitalization enhances clinical decision-making by providing objective data on air leaks, fluid drainage, and patient status. Digital chest drainage systems allow medical professionals to accurately monitor patients’ drainage levels and adjust the system settings remotely. This can help to reduce the number of hospital stays and enhance patient outcomes.

Rise in surgical procedures

More patients opting for surgical procedures, especially cardiac and thoracic surgeries, are expected to boost the global chest drainage system market. These systems are renowned for efficient post-operative fluid accumulation management and lung function maintenance.

Integration of digital technologies into chest drainage systems

The integration of digital technologies into chest drainage systems is gaining momentum. These systems now often come equipped with digital sensors and interfaces that enable real-time monitoring and data collection. Digitalization enhances clinical decision-making by providing objective data on air leaks, fluid drainage, and patient status.

Rising popularity of renewable chest drainage systems

The trend is toward reusable chest drainage systems that reduce medical waste and environmental impact. These systems are designed for longevity and are made of materials that can withstand multiple sterilization cycles. Reusable systems meet sustainability goals and offer long-term cost savings, making them an attractive option for healthcare facilities.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Chest Drainage System Market Trends

Increasing demand for minimally invasive approaches

Advances in medical technology are making minimally invasive chest drainage procedures more accessible and practical. These innovations include developing specialized equipment and techniques that allow healthcare providers to perform precise procedures with smaller incisions.

Integrating digital solutions further enhances the precision and monitoring of minimally invasive chest drainage. Minimally invasive approaches often involve smaller incisions and reduced exposure to external contaminants, leading to a lower risk of infection. Infection control is a paramount concern in healthcare settings, and this trend addresses that concern effectively.

Minimally invasive procedures, such as thoracentesis and video-assisted thoracoscopic surgery (VATS), are commonly used to diagnose and treat pleural effusion. Rise in their procedures is expected to drive demand for chest drainage systems as they play a crucial role by facilitating the safe and effective removal of fluid or air from the pleural cavity.

Transition towards next-generation chest drainage systems

The rising popularity of advanced solutions like smart chest drainage systems is expected to grow the chest drainage systems market. Smart’ or ‘connected’ chest drainage systems leverage advanced technology and connectivity to enhance patient care, streamline medical procedures, and improve healthcare outcomes.

Smart chest drainage systems are equipped with sensors and digital interfaces, allowing continuous, real-time monitoring of various parameters. This is a key factor boosting its demand since it allows for convenient monitoring of air leaks, fluid drainage rates, and pressure within the pleural cavity. Several smart chest drainage systems are designed with wireless connectivity options. This enables healthcare providers to monitor patient data through secure digital platforms remotely. Physicians can access vital information from their smartphones or computers, improving the efficiency of care.

Insights into Lucrative Opportunities Propelling Chest Drainage System Demand

The recent recommendation by the National Institute for Health and Care Excellence (NICE) to adopt Thopaz+ for chest drainage systems presents a substantial opportunity for growth in this business. NICE's endorsement, supported by cost modeling, indicates significant cost savings when using Thopaz+ compared to conventional systems. The estimated potential annual savings in the United States is expected to amount to about US$ 11.6 million. These savings primarily stem from reduced hospital stays, a critical factor in healthcare expenditures.

By shortening the drainage time and streamlining the length of patient hospitalization, Thopaz+ leads to financial efficiencies and enhances patient safety through continuous and objective monitoring of air leaks and fluid loss. This real-time monitoring allows healthcare professionals to intervene promptly, resulting in better patient management and potentially avoiding costly complications.

The endorsement of Thopaz+ encourages standardization of treatment protocols across wards, which can contribute to improved patient outcomes and more efficient healthcare delivery. Thopaz+ also equips clinicians with objective data, thereby enhancing clinical decision-making.

Lastly, the system promotes increased patient mobility, positively impacting patient satisfaction and overall recovery. The adoption of Thopaz+ not only represents substantial cost savings but also signifies an opportunity to elevate the quality of patient care, streamline healthcare processes, and promote innovative technology in improving healthcare outcomes while optimizing healthcare costs.

Key Challenges for Chest Drainage System Companies

The chest drainage system market faces a significant restraint in the form of a shortage of skilled healthcare professionals and the critical need for comprehensive training and education. Inefficient utilization of chest drainage systems, a direct consequence of inadequate training, will lead to suboptimal patient care and potentially life-threatening complications.

Safety concerns loom large as healthcare professionals struggle with the complexities of chest drainage technology, including setup, management, and troubleshooting. This lack of expertise hinders the full realization of the potential of advanced chest drainage systems and contributes to the delayed adoption of innovative solutions that could otherwise enhance patient care and outcomes.

Maintenance challenges further underscore the significance of this restraint, as the routine care, calibration, and timely troubleshooting of chest drainage systems necessitate knowledgeable personnel. Without skilled healthcare professionals, equipment downtime becomes a looming threat, potentially causing interruptions in patient care and exacerbating the challenges faced by healthcare institutions.

Related Business Growth Outlook Scenario

Particulars Value CAGR
Pleural Cavity Drainage Industry Outlook 5.1%
Surgical Drainage Device Industry Outlook 7.7%
Pleural Diseases Therapeutics Industry Outlook 6.5%

Comparative View of the Chest Drainage System Market

The chest drainage system market is likely to be impacted by the tangential or peer markets in the healthcare division. These include markets like surgical drainage devices and pleural diseases therapeutics. Knowledge of these related markets can help companies to get in-depth chest drainage system industry analysis.

Chest Drainage System Market:

Attributes Chest Drainage System Industry
CAGR (2023 to 2033) 5.5%
Sales Value (2023) US$ 1,795.93 million
Growth Factor Growing prevalence of cardiovascular diseases is expected to drive demand for chest drainage systems.
Key Trend Rising number of surgical procedures, especially thoracic surgeries, is likely to boost sales.

Surgical Drainage Device Market:

Attributes Surgical Drainage Device Industry
CAGR (2023 to 2033) 7.7%
Sales Value (2023) ~US$ 1.5 billion
Growth Factor Increasing incidence of chronic diseases is a prominent factor expected to fuel global sales of surgical drainage devices.
Key Trend Rising popularity of minimally invasive surgery is set to create new opportunities for surgical drainage device manufacturers.

Pleural Diseases Therapeutics Market:

Attributes Pleural Diseases Therapeutics Industry
CAGR (2023 to 2033) 6.5%
Sales Value (2023) US$ 4.98 billion
Growth Factor Rising cases of pleural disorders is anticipated to drive demand for pleural disease therapeutics.
Key Trend Growing health awareness and development of novel treatment methods will likely create growth prospects for pleural disease therapeutics companies.

Country-wise Insights

The table below highlights key countries’ chest drainage system market revenue. China, India, and the United States are expected to remain top markets for chest drainage systems, with expected valuations of US$ 189.49 million, US$ 176.50 million, and US$ 478.19 million, respectively, in 2033.

Countries Market Value (2033)
United States US$ 478.19 million
United Kingdom US$ 48.94 million
China US$ 189.49 million
Japan US$ 116.40 million
Germany US$ 80.91 million
India US$ 176.50 million
South Korea US$ 16.80 million

Below table shows the estimated growth rates of top five countries. South Korea and Japan are set to record higher CAGRs of 10.4% and 9.7%, respectively, through 2033.

Market Growth Outlook by Key Countries

Country Value CAGR
United States 3.6%
Germany 3.5%
United Kingdom 5.3%
Japan 9.7%
China 7.2%
South Korea 10.4%
India 7.1%

Rising Prevalence of Pneumothorax Driving Demand in the United States

The United States chest drainage system market is expected to register a CAGR of 3.6% during the forecast period. It is predicted to attain a valuation of US$ 478.19 million by 2033. Rapid expansion of healthcare infrastructure and growing prevalence of diseases like pneumothorax are uplifting chest drainage system demand.

The increasing prevalence of pneumothorax characterizes a notable trend in the chest drainage system market. In the United States alone, the annual incidence of primary spontaneous pneumothorax (PSP) is 7 cases per 100,000 men and 1 per 100,000 women, with recurrence rates ranging from 25% to 50%.

Secondary spontaneous pneumothorax (SSP) is also increasing. This is especially true for the elderly, aged 60 to 65, with an incidence of 6.3 cases per 100,000 men and 2 cases per 100,000 women. This trend underscores the urgent need for effective chest drainage systems to treat the increasing cases of pneumothorax, thereby driving demand.

The prevalence of pneumothorax exhibits gender and age disparities, with men being more susceptible than women in the United States. The male-to-female ratio is 3:1 for secondary spontaneous pneumothorax (SSP), highlighting the importance of tailoring solutions to different patient demographics.

As the aging population continues to increase, the incidence of pneumothorax in the elderly is expected to increase demand for chest drainage systems further. This will likely boost sales and improve the market share of the United States chest drainage system.

China to be the Next-door Opportunity for the Manufacturers

China is projected to continue experiencing high growth throughout the forecast period. As per the latest report, China chest drainage system market is set to register a CAGR of 7.2% throughout the forecast period. By 2033, total revenue in China is predicted to reach US$ 189.49 million.

In China, the prevalence of respiratory illnesses like pneumonia, lung cancer, and tuberculosis is on the rise, and this is a key driver for chest drainage system sales. Chest drainage techniques are frequently needed to treat and diagnose these illnesses.

Due to an increased geriatric population, respiratory illnesses and other chest-related health problems are becoming common in China. The demand for chest drainage devices is projected to rise as the older population increases.

According to a recent piece of Chinese literature, China has 2.5 million cases of pneumonia annually, and 125,000 (5%) of these people pass away from pneumonia-related conditions.

The use of chest drainage systems is frequent in pulmonary and cardiothoracic procedures. There is an ongoing need for these devices because China is performing an increasing number of these procedures.

India Becoming a Hotbed for Chest Drainage System Companies

India is emerging as a highly lucrative chest drainage system manufacturing company market. This is due to rising prevalence of cardiovascular diseases, growing health awareness, and expanding healthcare infrastructure.

As per latest chest drainage system market analysis, sales of chest drainage systems in India are expected to thrive at 7.1% CAGR during the forecast period. By 2033, India thoracic drainage device market or chest drainage systems market is set to attain a valuation of US$ 176.50 million.

Increased surgical operations require Chest drainage systems for post-operative care and complication management. These include cardiothoracic surgeries, lung transplants, and trauma surgeries.

According to the Lancet Commission for Global Surgery (LCoGS), 100,000 persons in LMICs would need 5,000 procedures to address the surgical burden of disease. Few studies from LMICs estimate surgical burden based on the number of procedures.

The effectiveness, safety, and simplicity of chest drainage devices have all been improved thanks to ongoing developments in chest drainage system technology. Hospitals and healthcare organizations will likely embrace newer, more efficient chest drainage methods, thereby bolstering sales in the country.

Funding for healthcare facilities, including the purchase of chest drainage devices, may increase due to government initiatives and policies targeted at enhancing healthcare services in India. This will present lucrative growth opportunities for chest drainage system companies.

Increasing Geriatric Population Driving Demand in Japan

Japan is forecast to experience robust growth during the forecast period. As per the latest report, the country's demand for chest drainage systems is set to rise at 9.7% CAGR over the forecast period.

By 2033, Japan chest drainage system market size is projected to reach US$ 116.40 million. This is attributable to rising geriatric population, expanding healthcare infrastructure, and growing cases of respiratory diseases like COPD.

According to the World Economic Forum, more than 1 in 10 people in Japan are aged 80 or older. This rising geriatric population is expected to positively impact chest drainage system demand as elderly people are more prone to suffer from respiratory diseases requiring chest drainage.

Japan government is also investing rigorously in expanding the country’s healthcare infrastructure. This is expected to create new opportunities for chest drainage system manufacturers.

Rising Incidence of Cardiovascular Diseases Driving Sales in the United Kingdom

Sales of chest drainage systems in the United Kingdom are anticipated to thrive at 5.3% CAGR during the forecast period. By 2033, the market value of the United Kingdom chest drainage system is predicted to total US$ 48.94 million.

Several factors are expected to fuel chest drainage system sales in the United Kingdom. These include increasing cardiovascular disease incidence, favorable reimbursement policies, and rising healthcare spending.

Cardiovascular diseases are the leading cause of death in the United Kingdom. As per the British Heart Foundation, heart and circulatory disease cause over 160,000 deaths each year in the United Kingdom. This is positively impacting sales in the country.

Chest drainage systems treat several cardiovascular conditions, including hemothorax and pleural effusions. As the cases of cardiovascular diseases continue to rise, so does demand for chest drainage systems.

Category-wise Insights

Pleural Drainage Systems to Remain Top Revenue-generation Product Category

Market Growth Outlook by Key Product Value CAGR
Pleural Drainage Systems 5.1%
Pleural Drainage Systems Kits 7.9%
Pleural Drainage Systems Accessories 10.2%

As per the latest chest drainage system market analysis, pleural drainage systems segment is expected to remain the top-revenue generation product category. It is predicted to thrive at a CAGR of 5.1%, totaling a valuation of US$ 1,479.44 million by 2033.

Pleural drainage systems are gaining wider popularity among end users for draining the pleural space. The management of certain thoracic and respiratory disorders depends heavily on these systems.

Systems for pleural drainage are adaptable and can be utilized for various medical procedures and ailments. This fuels their demand across hospitals, clinics, and other end use sectors.

Pleural drainage systems are crucial in thoracic and respiratory treatment since they are not restricted to a particular procedure or technique. The ability of pleural drainage systems to effectively remove air, blood, or fluids from the pleural space is expected to fuel their demand through 2033.

Overview of Leading Indication in the Global Chest Drainage System Market

Pleural Effusion to Hold a Prominent Market Share through 2033

Market Growth Outlook by Key Indication Value CAGR
Pleural Effusion 4.5%
Hemothorax 6.3%
Spontaneous Pneumothorax 10.7%
Tension Pneumothorax 9.5%
Traumatic Pneumothorax 8.8%
Cardiac Tamponade 7.3%
Coronary artery bypass grafting (CABG) Procedures 4.8%
Open Heart Surgeries 6.1%

Based on indication, pleural effusion currently dominates the global chest drainage system industry, and the trend is expected to continue through 2033. This is due to rising prevalence of pleural effusion and growing need for treating this disease.

Pleural effusion is a relatively common medical illness in which fluid accumulation occurs between the parietal and visceral pleura. Numerous underlying factors and medical disorders can contribute to this illness. For instance,

According to the journal of the National Institutes of Health, in developed nations, the prevalence of pleural effusion is estimated to be 320 instances per 100,000 persons, with a variety of etiologies related to the frequency of underlying disorders.

Patients suffering from pleural effusion often opt for medical procedures for managing and treating this disease. This is expected to drive demand for chest drainage systems as they are employed to remove the fluid. Certain indwelling catheters also allow patients with recurrent effusions to be managed at home. Thus, increasing cases of pleural effusion will play a key role in boosting the chest drainage system industry.

As per the latest chest drainage system industry analysis, pleural effusion segment is projected to thrive at 4.5% CAGR during the assessment period. It is set to total a valuation of US$ 747.97 million by 2033.

Details on Leading End Users within the Global Chest Drainage System Market

Adoption of Chest Drainage Systems to Remain High in Hospitals

Market Growth Outlook by Key End User Value CAGR
Hospitals 4.4%
Specialty Clinics 8.9%
Ambulatory Surgical Centers 5.6%

The hospital segment is anticipated to dominate the target market with a share of around 42.2% in 2033. It is poised to exhibit a CAGR of 4.4% during the forecast period. This is attributable to rising number of hospitals, increasing patient flow, and adoption of chest drainage systems in these settings.

Hospitals are essential healthcare facilities that are crucial in detecting, treating, and managing cardiovascular disease. They provide various solutions and chest drainage systems for cardiovascular disease patients, such as diagnostic procedures, surgical interventions, and rehabilitation programs.

Modern medical technology, experienced cardiologists, and interdisciplinary teams are all found in hospitals, providing efficient patient care and illness control. Hospitals are crucial recipients of developments and innovations in the worldwide chest drainage system market. This is because of their central role in treating diseases such as pleural effusion, hemothorax, pneumothorax, etc.

Hospitals are investing in novel medical technologies and products to improve patient outcomes and boost the effectiveness of healthcare as a whole. This is expected to create growth prospects for chest drainage system manufacturers.

Competitive Landscape

Geographic expansions are a priority for leading chest drainage systems companies. They work to create new product lines and expand their global consumer base. Top manufacturers of chest drainage systems are also implementing strategies like partnerships, acquisitions, mergers, and collaborations to solidify their market positions.

Recent Chest Drainage System Market Developments:

  • In April 2023, Teleflex Incorporated commenced construction on an expansion project for its Teleflex Medical facility of OEM in Jaffrey. This project involves the construction of a new facility spanning over 8,200 square feet, aimed at increasing the extrusion capacity.
  • In January 2022, B. Braun Medical Inc. disclosed a collaboration partnership with Massachusetts General Hospital (MGH), a renowned research hospital in the United States.

Chest Drainage System Market Report Scope

Attribute Details
Estimated Market Value (2023) US$ 1,034.25 million
Projected Market Size (2033) US$ 1,795.93 Million
Expected Growth Rate (2023 to 2033) 5.7%
Forecast Period 2023 to 2033
Historical Data Available for 2017 to 2022
Market Analysis US$ Million for Value
Key Regions Covered North America, Latin America, East Asia, South Asia Pacific, Western Europe, Eastern Europe, Central Asia, Russia & Belarus, Balkan & Baltic Countries, Middle East & Africa.
Key Countries Covered United States, Canada, Brazil, Mexico, Argentina, Chile, Peru, Colombia, China, Japan, South Korea, India, Indonesia, Thailand, Philippines, Malaysia, Vietnam, Australia and New Zealand, United Kingdom, Germany, France, Spain, Italy, BENELUX, Nordic Countries, Poland, Hungary, Romania, Czech Republic, GCC Countries, Türkiye, Northern Africa, South Africa, Israel.
Key Market Segments Covered Product, Indication, End-user, and Region
Key Companies Profiled
  • Teleflex Incorporated
  • B. Braun Melsungen AG
  • Smiths Medical (ICU Medical Inc.)
  • Becton, Dickinson and Company
  • Cardinal Health
  • Redax S.p.A.
  • Merit Medical Systems
  • Getinge AB
  • Rocket Medical plc.
  • Grena Ltd.
  • Sterimed Group
  • pfm medical ag
  • Medela AG
  • Sinapi Biomedical
  • ATMOS MedizinTechnik GmbH & Co. KG
  • unimax Medical Systems Inc.
  • Ningbo Xinwell Medical Technology Co., LTD.
  • Cook
Report Coverage Market Forecast, Competition Intelligence, DROT Analysis, Dynamics and Challenges, Strategic Growth Initiatives

Chest Drainage System Market Segmentation

By Product:

  • Pleural Drainage Systems
    • Traditional Pleural Drainage Systems
    • Digital Pleural Drainage Systems
  • Pleural Drainage Systems Kits
  • Pleural Drainage Systems Accessories

By Indication:

  • Pleural Effusion
  • Hemothorax
  • Spontaneous Pneumothorax
  • Tension Pneumothorax
  • Traumatic Pneumothorax
  • Cardiac Tamponade
  • Coronary artery bypass grafting (CABG) Procedures
  • Open Heart Surgeries

By End-user:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • East Asia
  • South Asia & Pacific
  • Western Europe
  • Eastern Europe
  • Central Asia
  • Russia & Belarus
  • Balkan & Baltic Countries
  • Middle East & Africa

Frequently Asked Questions

How big was the global market for chest drainage systems in 2022?

The global market was valued at around US$ 977.91 million in 2022.

What is the current size of the chest drainage system market?

In 2023, the global market size is set to reach US$ 1,034.25 million.

What is the predicted valuation for the global market in 2033?

The global market is set to reach US$ 1,795.93 million by 2033.

Which product segment dominates the market?

With 82.4% share in 2033, pleural drainage systems will dominate the market.

What was the last 5 years’ CAGR for the global market?

The global market exhibited a 4.3% CAGR from 2017 to 2022.

What is the demand outlook for the chest drainage system?

Chest drainage system demand is expected to rise at 5.7% CAGR through 2033.

What is the success rate of chest drainage?

The success rate of chest drainage is between 70 to 90%.

What is the demand outlook for the chest drainage system?

Chest drainage system demand is expected to rise at 5.7% CAGR through 2033.

What is the goal of chest drainage system?

The goal of chest drainage system is to remove fluid, air, or blood from the pleural space.

What is the chest drainage system market size in the United States?

The United States market size is set to reach US$ 478.19 million by 2033.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply-Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Development/Innovation Trends

4. Value-Added Insights

    4.1. Product Assessment

        4.1.1. Product Adoption Analysis

        4.1.2. Product Mapping Analysis

    4.2. Disease Epidemiology, By Country

        4.2.1. Pleural Effusion

        4.2.2. Hemothorax

        4.2.3. Spontaneous Pneumothorax

        4.2.4. Tension Pneumothorax

        4.2.5. Traumatic Pneumothorax

        4.2.6. Cardiac Tamponade

    4.3. Installed Base Analysis by Region

    4.4. Number of Coronary Artery Bypass Grafting (CABG) Procedures

    4.5. Number of Open Heart Surgeries (OHS) Procedures

    4.6. Regulatory Scenario

        4.6.1. Regulatory Frameworks in United States

        4.6.2. Regulatory Frameworks in Europe

        4.6.3. Regulatory Frameworks in China

        4.6.4. Regulatory Frameworks in Japan

        4.6.5. Regulatory Frameworks in India

        4.6.6. Regulatory Frameworks in Australia

        4.6.7. Regulatory Frameworks in Middle East & Africa

    4.7. PESTLE Analysis by Region

    4.8. PORTER Analysis

    4.9. Value Chain Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global Healthcare Expenditure Outlook

        5.1.2. R&D Funding By Region

        5.1.3. R&D Funding By Country

        5.1.4. Global Life Expectancy Outlook

        5.1.5. Global Parent Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Prevalence of Respiratory Conditions

        5.2.2. Advancements in Medical Technology

        5.2.3. Surgical Procedures and Hospitalization Rates

        5.2.4. Aging Population

        5.2.5. Healthcare Infrastructure & Development

        5.2.6. Infection Control Measures

        5.2.7. Increasing Healthcare Spending

        5.2.8. Patient-Centered Care

        5.2.9. Competitive Landscape and Technological Innovation

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. Global Market Demand (in Volume Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033

    6.1. Historical Market Volume (Units) Analysis, 2017 to 2022

    6.2. Current and Future Market Volume (Units) Projections, 2023 to 2033

        6.2.1. Y-o-Y Growth Trend Analysis

7. Global Market - Pricing Assessment

    7.1. Regional Pricing Analysis, By Product

    7.2. Global Average Pricing Analysis Benchmark, By Product

    7.3. Pricing Assumptions

8. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033

    8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022

    8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

    8.3. Revenue Opportunity Scenario

9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2017 to 2022

    9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033

        9.3.1. Pleural Drainage Systems

            9.3.1.1. Traditional Pleural Drainage Systems

            9.3.1.2. Digital Pleural Drainage Systems

        9.3.2. Pleural Drainage Systems Kits

        9.3.3. Pleural Drainage Systems Accessories

    9.4. Market Attractiveness Analysis By Product

10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Indication

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) By Indication, 2017 to 2022

    10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Indication, 2023 to 2033

        10.3.1. Pleural Effusion

        10.3.2. Hemothorax

        10.3.3. Spontaneous Pneumothorax

        10.3.4. Tension Pneumothorax

        10.3.5. Traumatic Pneumothorax

        10.3.6. Cardiac Tamponade

        10.3.7. Coronary Artery Bypass Grafting (CABG) Procedures

        10.3.8. Open Heart Surgeries

    10.4. Market Attractiveness Analysis By Indication

11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Million) By End User, 2017 to 2022

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast by End User, 2023 to 2033

        11.3.1. Hospitals

        11.3.2. Specialty Clinics

        11.3.3. Ambulatory Surgical Centers

    11.4. Market Attractiveness Analysis by End User

12. Global Market: Cross Sectional Analysis - Product Vs End User

    12.1. Historical Market Size (US$ Million) By Product Vs End User, 2017 to 2022

    12.2. Current and Future Market Size (US$ Million) Analysis and Forecast by Product Vs End User, 2023 to 2033

        12.2.1. Pleural Drainage Systems

            12.2.1.1. Hospitals

            12.2.1.2. Specialty Clinics

            12.2.1.3. Ambulatory Surgical Centers

        12.2.2. Pleural Drainage Systems Kits

            12.2.2.1. Hospitals

            12.2.2.2. Specialty Clinics

            12.2.2.3. Ambulatory Surgical Centers

        12.2.3. Pleural Drainage Systems Accessories

            12.2.3.1. Hospitals

            12.2.3.2. Specialty Clinics

            12.2.3.3. Ambulatory Surgical Centers

13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Region, 2017 to 2022

    13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Region, 2023 to 2033

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. East Asia

        13.3.4. South Asia & Pacific

        13.3.5. Western Europe

        13.3.6. Eastern Europe

        13.3.7. Central Asia

        13.3.8. Russia & Belarus

        13.3.9. Balkan & Baltic Countries

        13.3.10. Middle East & Africa

    13.4. Market Attractiveness Analysis by Region

14. North America Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    14.1. Introduction

    14.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022

    14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        14.3.1. By Country

            14.3.1.1. United States

            14.3.1.2. Canada

        14.3.2. By Product

        14.3.3. By Indication

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Product

        14.4.3. By Indication

        14.4.4. By End User

    14.5. Market Trends

    14.6. Drivers & Restraints Impact Analysis

    14.7. Country-Wise Analysis

        14.7.1. United States Market Analysis

            14.7.1.1. Introduction

            14.7.1.2. Market Analysis and Forecast by Market Taxonomy

                14.7.1.2.1. By Product

                14.7.1.2.2. By Indication

                14.7.1.2.3. By End User

        14.7.2. Canada Market Analysis

            14.7.2.1. Introduction

            14.7.2.2. Market Analysis and Forecast by Market Taxonomy

                14.7.2.2.1. By Product

                14.7.2.2.2. By Indication

                14.7.2.2.3. By End User

15. Latin America Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    15.1. Introduction

    15.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022

    15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        15.3.1. By Country

            15.3.1.1. Brazil

            15.3.1.2. Mexico

            15.3.1.3. Argentina

            15.3.1.4. Peru

            15.3.1.5. Chile

            15.3.1.6. Columbia

            15.3.1.7. Rest of Latin America

        15.3.2. By Product

        15.3.3. By Indication

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Product

        15.4.3. By Indication

        15.4.4. By End User

    15.5. Market Trends

    15.6. Drivers & Restraints Impact Analysis

    15.7. Country-Wise Analysis

        15.7.1. Brazil Market Analysis

            15.7.1.1. Introduction

            15.7.1.2. Market Analysis and Forecast by Market Taxonomy

                15.7.1.2.1. By Product

                15.7.1.2.2. By Indication

                15.7.1.2.3. By End User

        15.7.2. Mexico Market Analysis

            15.7.2.1. Introduction

            15.7.2.2. Market Analysis and Forecast by Market Taxonomy

                15.7.2.2.1. By Product

                15.7.2.2.2. By Indication

                15.7.2.2.3. By End User

        15.7.3. Argentina Market Analysis

            15.7.3.1. Introduction

            15.7.3.2. Market Analysis and Forecast by Market Taxonomy

                15.7.3.2.1. By Product

                15.7.3.2.2. By Indication

                15.7.3.2.3. By End User

        15.7.4. Peru Market Analysis

            15.7.4.1. Introduction

            15.7.4.2. Market Analysis and Forecast by Market Taxonomy

                15.7.4.2.1. By Product

                15.7.4.2.2. By Indication

                15.7.4.2.3. By End User

        15.7.5. Chile Market Analysis

            15.7.5.1. Introduction

            15.7.5.2. Market Analysis and Forecast by Market Taxonomy

                15.7.5.2.1. By Product

                15.7.5.2.2. By Indication

                15.7.5.2.3. By End User

        15.7.6. Columbia Market Analysis

            15.7.6.1. Introduction

            15.7.6.2. Market Analysis and Forecast by Market Taxonomy

                15.7.6.2.1. By Product

                15.7.6.2.2. By Indication

                15.7.6.2.3. By End User

16. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    16.1. Introduction

    16.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022

    16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        16.3.1. By Country

            16.3.1.1. China

            16.3.1.2. Japan

            16.3.1.3. South Korea

        16.3.2. By Product

        16.3.3. By Indication

        16.3.4. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Product

        16.4.3. By Indication

        16.4.4. By End User

    16.5. Market Trends

    16.6. Drivers & Restraints Impact Analysis

    16.7. Country-Wise Analysis

        16.7.1. China Market Analysis

            16.7.1.1. Introduction

            16.7.1.2. Market Analysis and Forecast by Market Taxonomy

                16.7.1.2.1. By Product

                16.7.1.2.2. By Indication

                16.7.1.2.3. By End User

        16.7.2. Japan Market Analysis

            16.7.2.1. Introduction

            16.7.2.2. Market Analysis and Forecast by Market Taxonomy

                16.7.2.2.1. By Product

                16.7.2.2.2. By Indication

                16.7.2.2.3. By End User

        16.7.3. South Korea Market Analysis

            16.7.3.1. Introduction

            16.7.3.2. Market Analysis and Forecast by Market Taxonomy

                16.7.3.2.1. By Product

                16.7.3.2.2. By Indication

                16.7.3.2.3. By End User

17. South Asia & Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    17.1. Introduction

    17.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022

    17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        17.3.1. By Country

            17.3.1.1. India

            17.3.1.2. Indonesia

            17.3.1.3. Philippines

            17.3.1.4. Thailand

            17.3.1.5. Malaysia

            17.3.1.6. Vietnam

            17.3.1.7. Australia & New Zealand

            17.3.1.8. Rest of South Asia

        17.3.2. By Product

        17.3.3. By Indication

        17.3.4. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product

        17.4.3. By Indication

        17.4.4. By End User

    17.5. Market Trends

    17.6. Drivers & Restraints Impact Analysis

    17.7. Country-Wise Analysis

        17.7.1. India Market Analysis

            17.7.1.1. Introduction

            17.7.1.2. Market Analysis and Forecast by Market Taxonomy

                17.7.1.2.1. By Product

                17.7.1.2.2. By Indication

                17.7.1.2.3. By End User

        17.7.2. Indonesia Market Analysis

            17.7.2.1. Introduction

            17.7.2.2. Market Analysis and Forecast by Market Taxonomy

                17.7.2.2.1. By Product

                17.7.2.2.2. By Indication

                17.7.2.2.3. By End User

        17.7.3. Philippines Market Analysis

            17.7.3.1. Introduction

            17.7.3.2. Market Analysis and Forecast by Market Taxonomy

                17.7.3.2.1. By Product

                17.7.3.2.2. By Indication

                17.7.3.2.3. By End User

        17.7.4. Thailand Market Analysis

            17.7.4.1. Introduction

            17.7.4.2. Market Analysis and Forecast by Market Taxonomy

                17.7.4.2.1. By Product

                17.7.4.2.2. By Indication

                17.7.4.2.3. By End User

        17.7.5. Malaysia Market Analysis

            17.7.5.1. Introduction

            17.7.5.2. Market Analysis and Forecast by Market Taxonomy

                17.7.5.2.1. By Product

                17.7.5.2.2. By Indication

                17.7.5.2.3. By End User

        17.7.6. Vietnam Market Analysis

            17.7.6.1. Introduction

            17.7.6.2. Market Analysis and Forecast by Market Taxonomy

                17.7.6.2.1. By Product

                17.7.6.2.2. By Indication

                17.7.6.2.3. By End User

        17.7.7. Australia & New Zealand Market Analysis

            17.7.7.1. Introduction

            17.7.7.2. Market Analysis and Forecast by Market Taxonomy

                17.7.7.2.1. By Product

                17.7.7.2.2. By Indication

                17.7.7.2.3. By End User

18. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    18.1. Introduction

    18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022

    18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        18.3.1. By Country

            18.3.1.1. Germany

            18.3.1.2. France

            18.3.1.3. Spain

            18.3.1.4. Italy

            18.3.1.5. BENELUX

            18.3.1.6. Nordic Countries

            18.3.1.7. United Kingdom

        18.3.2. By Product

        18.3.3. By Indication

        18.3.4. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Product

        18.4.3. By Indication

        18.4.4. By End User

    18.5. Market Trends

    18.6. Drivers & Restraints Impact Analysis

    18.7. Country-Wise Analysis

        18.7.1. Germany Market Analysis

            18.7.1.1. Introduction

            18.7.1.2. Market Analysis and Forecast by Market Taxonomy

                18.7.1.2.1. By Product

                18.7.1.2.2. By Indication

                18.7.1.2.3. By End User

        18.7.2. France Market Analysis

            18.7.2.1. Introduction

            18.7.2.2. Market Analysis and Forecast by Market Taxonomy

                18.7.2.2.1. By Product

                18.7.2.2.2. By Indication

                18.7.2.2.3. By End User

        18.7.3. Spain Market Analysis

            18.7.3.1. Introduction

            18.7.3.2. Market Analysis and Forecast by Market Taxonomy

                18.7.3.2.1. By Product

                18.7.3.2.2. By Indication

                18.7.3.2.3. By End User

        18.7.4. Italy Republic Market Analysis

            18.7.4.1. Introduction

            18.7.4.2. Market Analysis and Forecast by Market Taxonomy

                18.7.4.2.1. By Product

                18.7.4.2.2. By Indication

                18.7.4.2.3. By End User

        18.7.5. BENELUX Republic Market Analysis

            18.7.5.1. Introduction

            18.7.5.2. Market Analysis and Forecast by Market Taxonomy

                18.7.5.2.1. By Product

                18.7.5.2.2. By Indication

                18.7.5.2.3. By End User

        18.7.6. Nordic Countries Market Analysis

            18.7.6.1. Introduction

            18.7.6.2. Market Analysis and Forecast by Market Taxonomy

                18.7.6.2.1. By Product

                18.7.6.2.2. By Indication

                18.7.6.2.3. By End User

        18.7.7. United Kingdom Market Analysis

            18.7.7.1. Introduction

            18.7.7.2. Market Analysis and Forecast by Market Taxonomy

                18.7.7.2.1. By Product

                18.7.7.2.2. By Indication

                18.7.7.2.3. By End User

19. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    19.1. Introduction

    19.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022

    19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        19.3.1. By Country

            19.3.1.1. Poland

            19.3.1.2. Hungary

            19.3.1.3. Romania

            19.3.1.4. Czech Republic

            19.3.1.5. Rest of Eastern Europe

        19.3.2. By Product

        19.3.3. By Indication

        19.3.4. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Product

        19.4.3. By Indication

        19.4.4. By End User

    19.5. Drivers & Restraints Impact Analysis

    19.6. Country-Wise Analysis

        19.6.1. Poland Market Analysis

            19.6.1.1. Introduction

            19.6.1.2. Market Analysis and Forecast by Market Taxonomy

                19.6.1.2.1. By Product

                19.6.1.2.2. By Indication

                19.6.1.2.3. By End User

        19.6.2. Hungary Market Analysis

            19.6.2.1. Introduction

            19.6.2.2. Market Analysis and Forecast by Market Taxonomy

                19.6.2.2.1. By Product

                19.6.2.2.2. By Indication

                19.6.2.2.3. By End User

        19.6.3. Romania Market Analysis

            19.6.3.1. Introduction

            19.6.3.2. Market Analysis and Forecast by Market Taxonomy

                19.6.3.2.1. By Product

                19.6.3.2.2. By Indication

                19.6.3.2.3. By End User

        19.6.4. Czech Republic Market Analysis

            19.6.4.1. Introduction

            19.6.4.2. Market Analysis and Forecast by Market Taxonomy

                19.6.4.2.1. By Product

                19.6.4.2.2. By Indication

                19.6.4.2.3. By End User

20. Central Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    20.1. Introduction

    20.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022

    20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        20.3.1. By Product

        20.3.2. By Indication

        20.3.3. By End User

    20.4. Market Attractiveness Analysis

        20.4.1. By Product

        20.4.2. By Indication

        20.4.3. By End User

    20.5. Drivers & Restraints Impact Analysis

21. Russia & Belarus Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    21.1. Introduction

    21.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022

    21.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        21.3.1. By Product

        21.3.2. By Indication

        21.3.3. By End User

    21.4. Market Attractiveness Analysis

        21.4.1. By Product

        21.4.2. By Indication

        21.4.3. By End User

    21.5. Drivers & Restraints Impact Analysis

22. Balkan & Baltic Countries Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    22.1. Introduction

    22.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022

    22.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        22.3.1. By Product

        22.3.2. By Indication

        22.3.3. By End User

    22.4. Market Attractiveness Analysis

        22.4.1. By Product

        22.4.2. By Indication

        22.4.3. By End User

    22.5. Drivers & Restraints Impact Analysis

23. Middle East & Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033

    23.1. Introduction

    23.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022

    23.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        23.3.1. By Country

            23.3.1.1. GCC Countries

            23.3.1.2. Türkiye

            23.3.1.3. Northern Africa

            23.3.1.4. South Africa

            23.3.1.5. Israel

            23.3.1.6. Rest of Middle East & Africa

        23.3.2. By Product

        23.3.3. By Indication

        23.3.4. By End User

    23.4. Market Attractiveness Analysis

        23.4.1. By Country

        23.4.2. By Product

        23.4.3. By Indication

        23.4.4. By End User

    23.5. Market Trends

    23.6. Drivers & Restraints Impact Analysis

    23.7. Country-Wise Analysis

        23.7.1. GCC Countries Market Analysis

            23.7.1.1. Introduction

            23.7.1.2. Market Analysis and Forecast by Market Taxonomy

                23.7.1.2.1. By Product

                23.7.1.2.2. By Indication

                23.7.1.2.3. By End User

        23.7.2. Kingdom of Saudi Arabia Market Analysis

            23.7.2.1. Introduction

            23.7.2.2. Market Analysis and Forecast by Market Taxonomy

                23.7.2.2.1. By Product

                23.7.2.2.2. By Indication

                23.7.2.2.3. By End User

        23.7.3. Türkiye Market Analysis

            23.7.3.1. Introduction

            23.7.3.2. Market Analysis and Forecast by Market Taxonomy

                23.7.3.2.1. By Product

                23.7.3.2.2. By Indication

                23.7.3.2.3. By End User

        23.7.4. Northern Africa Market Analysis

            23.7.4.1. Introduction

            23.7.4.2. Market Analysis and Forecast by Market Taxonomy

                23.7.4.2.1. By Product

                23.7.4.2.2. By Indication

                23.7.4.2.3. By End User

        23.7.5. South Africa Market Analysis

            23.7.5.1. Introduction

            23.7.5.2. Market Analysis and Forecast by Market Taxonomy

                23.7.5.2.1. By Product

                23.7.5.2.2. By Indication

                23.7.5.2.3. By End User

        23.7.6. Israel Market Analysis

            23.7.6.1. Introduction

            23.7.6.2. Market Analysis and Forecast by Market Taxonomy

                23.7.6.2.1. By Product

                23.7.6.2.2. By Indication

                23.7.6.2.3. By End User

24. Market Structure Analysis

    24.1. Market Analysis by Tier of Companies

    24.2. Market Share Analysis of Top Players (%)

25. Competition Analysis

    25.1. Competition Dashboard

    25.2. Competition Benchmarking

    25.3. Branding and Promotional Strategies, By Key Manufactures

    25.4. Key Development Analysis

    25.5. Competition Deep Dive

        25.5.1. Teleflex Incorporated

            25.5.1.1. Overview

            25.5.1.2. Product Portfolio

            25.5.1.3. Key Financials

            25.5.1.4. SWOT Analysis

            25.5.1.5. Key Developments

            25.5.1.6. Sales Footprint

            25.5.1.7. Strategy Overview

                25.5.1.7.1. Marketing Strategy

                25.5.1.7.2. Product Strategy

                25.5.1.7.3. Channel Strategy

        25.5.2. B. Braun Melsungen AG

            25.5.2.1. Overview

            25.5.2.2. Product Portfolio

            25.5.2.3. Key Financials

            25.5.2.4. SWOT Analysis

            25.5.2.5. Key Developments

            25.5.2.6. Sales Footprint

            25.5.2.7. Strategy Overview

                25.5.2.7.1. Marketing Strategy

                25.5.2.7.2. Product Strategy

                25.5.2.7.3. Channel Strategy

        25.5.3. Smith’s Medical (ICU Medical Inc.)

            25.5.3.1. Overview

            25.5.3.2. Product Portfolio

            25.5.3.3. Key Financials

            25.5.3.4. SWOT Analysis

            25.5.3.5. Key Developments

            25.5.3.6. Sales Footprint

            25.5.3.7. Strategy Overview

                25.5.3.7.1. Marketing Strategy

                25.5.3.7.2. Product Strategy

                25.5.3.7.3. Channel Strategy

        25.5.4. Becton, Dickinson and Company

            25.5.4.1. Overview

            25.5.4.2. Product Portfolio

            25.5.4.3. Key Financials

            25.5.4.4. SWOT Analysis

            25.5.4.5. Key Developments

            25.5.4.6. Sales Footprint

            25.5.4.7. Strategy Overview

                25.5.4.7.1. Marketing Strategy

                25.5.4.7.2. Product Strategy

                25.5.4.7.3. Channel Strategy

        25.5.5. Cardinal Health

            25.5.5.1. Overview

            25.5.5.2. Product Portfolio

            25.5.5.3. Key Financials

            25.5.5.4. SWOT Analysis

            25.5.5.5. Key Developments

            25.5.5.6. Sales Footprint

            25.5.5.7. Strategy Overview

                25.5.5.7.1. Marketing Strategy

                25.5.5.7.2. Product Strategy

                25.5.5.7.3. Channel Strategy

        25.5.6. Redax S.p.A.

            25.5.6.1. Overview

            25.5.6.2. Product Portfolio

            25.5.6.3. Key Financials

            25.5.6.4. SWOT Analysis

            25.5.6.5. Key Developments

            25.5.6.6. Sales Footprint

            25.5.6.7. Strategy Overview

                25.5.6.7.1. Marketing Strategy

                25.5.6.7.2. Product Strategy

                25.5.6.7.3. Channel Strategy

        25.5.7. Merit Medical Systems

            25.5.7.1. Overview

            25.5.7.2. Product Portfolio

            25.5.7.3. Key Financials

            25.5.7.4. SWOT Analysis

            25.5.7.5. Key Developments

            25.5.7.6. Sales Footprint

            25.5.7.7. Strategy Overview

                25.5.7.7.1. Marketing Strategy

                25.5.7.7.2. Product Strategy

                25.5.7.7.3. Channel Strategy

        25.5.8. Getinge AB

            25.5.8.1. Overview

            25.5.8.2. Product Portfolio

            25.5.8.3. Key Financials

            25.5.8.4. SWOT Analysis

            25.5.8.5. Key Developments

            25.5.8.6. Sales Footprint

            25.5.8.7. Strategy Overview

                25.5.8.7.1. Marketing Strategy

                25.5.8.7.2. Product Strategy

                25.5.8.7.3. Channel Strategy

        25.5.9. Rocket Medical plc.

            25.5.9.1. Overview

            25.5.9.2. Product Portfolio

            25.5.9.3. Key Financials

            25.5.9.4. SWOT Analysis

            25.5.9.5. Key Developments

            25.5.9.6. Sales Footprint

            25.5.9.7. Strategy Overview

                25.5.9.7.1. Marketing Strategy

                25.5.9.7.2. Product Strategy

                25.5.9.7.3. Channel Strategy

        25.5.10. Grena Ltd.

            25.5.10.1. Overview

            25.5.10.2. Product Portfolio

            25.5.10.3. Key Financials

            25.5.10.4. SWOT Analysis

            25.5.10.5. Key Developments

            25.5.10.6. Sales Footprint

            25.5.10.7. Strategy Overview

                25.5.10.7.1. Marketing Strategy

                25.5.10.7.2. Product Strategy

                25.5.10.7.3. Channel Strategy

        25.5.11. Sterimed Group

            25.5.11.1. Overview

            25.5.11.2. Product Portfolio

            25.5.11.3. Key Financials

            25.5.11.4. SWOT Analysis

            25.5.11.5. Key Developments

            25.5.11.6. Sales Footprint

            25.5.11.7. Strategy Overview

                25.5.11.7.1. Marketing Strategy

                25.5.11.7.2. Product Strategy

                25.5.11.7.3. Channel Strategy

        25.5.12. pfm medical ag

            25.5.12.1. Overview

            25.5.12.2. Product Portfolio

            25.5.12.3. Key Financials

            25.5.12.4. SWOT Analysis

            25.5.12.5. Key Developments

            25.5.12.6. Sales Footprint

            25.5.12.7. Strategy Overview

                25.5.12.7.1. Marketing Strategy

                25.5.12.7.2. Product Strategy

                25.5.12.7.3. Channel Strategy

        25.5.13. Medela AG

            25.5.13.1. Overview

            25.5.13.2. Product Portfolio

            25.5.13.3. Key Financials

            25.5.13.4. SWOT Analysis

            25.5.13.5. Key Developments

            25.5.13.6. Sales Footprint

            25.5.13.7. Strategy Overview

                25.5.13.7.1. Marketing Strategy

                25.5.13.7.2. Product Strategy

                25.5.13.7.3. Channel Strategy

        25.5.14. Sinapi Biomedical

            25.5.14.1. Overview

            25.5.14.2. Product Portfolio

            25.5.14.3. Key Financials

            25.5.14.4. SWOT Analysis

            25.5.14.5. Key Developments

            25.5.14.6. Sales Footprint

            25.5.14.7. Strategy Overview

                25.5.14.7.1. Marketing Strategy

                25.5.14.7.2. Product Strategy

                25.5.14.7.3. Channel Strategy

        25.5.15. ATMOS MedizinTechnik GmbH & Co. KG

            25.5.15.1. Overview

            25.5.15.2. Product Portfolio

            25.5.15.3. Key Financials

            25.5.15.4. SWOT Analysis

            25.5.15.5. Key Developments

            25.5.15.6. Sales Footprint

            25.5.15.7. Strategy Overview

                25.5.15.7.1. Marketing Strategy

                25.5.15.7.2. Product Strategy

                25.5.15.7.3. Channel Strategy

        25.5.16. unimax medical systems inc.

            25.5.16.1. Overview

            25.5.16.2. Product Portfolio

            25.5.16.3. Key Financials

            25.5.16.4. SWOT Analysis

            25.5.16.5. Key Developments

            25.5.16.6. Sales Footprint

            25.5.16.7. Strategy Overview

                25.5.16.7.1. Marketing Strategy

                25.5.16.7.2. Product Strategy

                25.5.16.7.3. Channel Strategy

        25.5.17. Ningbo Xinwell Medical Technology Co., LTD.

            25.5.17.1. Overview

            25.5.17.2. Product Portfolio

            25.5.17.3. Key Financials

            25.5.17.4. SWOT Analysis

            25.5.17.5. Key Developments

            25.5.17.6. Sales Footprint

            25.5.17.7. Strategy Overview

                25.5.17.7.1. Marketing Strategy

                25.5.17.7.2. Product Strategy

                25.5.17.7.3. Channel Strategy

        25.5.18. Cook

            25.5.18.1. Overview

            25.5.18.2. Product Portfolio

            25.5.18.3. Key Financials

            25.5.18.4. SWOT Analysis

            25.5.18.5. Key Developments

            25.5.18.6. Sales Footprint

            25.5.18.7. Strategy Overview

                25.5.18.7.1. Marketing Strategy

                25.5.18.7.2. Product Strategy

                25.5.18.7.3. Channel Strategy

26. Assumptions and Acronyms Used

27. Research Methodology

Recommendations

Healthcare

Pleural Diseases Therapeutics Market

January 2023

REP-GB-16576

291 pages

Healthcare

Malignant Pleural Effusion Market

December 2022

REP-GB-16230

280 pages

Healthcare

Surgical Drainage Devices Market

December 2022

REP-GB-15869

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Chest Drainage System Market